Zinman, Bernard
Bhosekar, Vaishali
Busch, Robert
Holst, Ingrid
Ludvik, Bernhard
Thielke, Desirée
Thrasher, James
Woo, Vincent
Philis-Tsimikas, Athena
This article is maintained by: Elsevier
Article Title: Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
Journal Title: The Lancet Diabetes & Endocrinology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2213-8587(19)30066-X
CrossRef DOI link to the associated document: https://doi.org/10.1016/S2213-8587(19)30069-5
Content Type: article
Copyright: © 2019 Elsevier Ltd. All rights reserved.